Skip to main content

Month: June 2020

SEACOR Marine Announces Agreement to Consolidate SEACOSCO Joint Venture

HOUSTON, June 04, 2020 (GLOBE NEWSWIRE) — SEACOR Marine Holdings Inc. (NYSE: SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore oil and natural gas and wind farm facilities worldwide, today announced that a wholly-owned subsidiary of the Company entered into a definitive sale and purchase agreement to acquire the remaining 50% of the equity interests in SEACOSCO Offshore LLC (“SEACOSCO”) that it did not already own from affiliates of COSCO SHIPPING GROUP (“COSCO”).  As a result of the purchase, SEACOR Marine will own 100% of SEACOSCO.  Subject to the satisfaction of the conditions to closing, the transaction is expected to close in June 2020.The acquisition further modernizes SEACOR Marine’s fleet through consolidating the Company’s ownership of eight Rolls-Royce...

Continue reading

Adamas announces FDA filing acceptance of sNDA to modify the indication statement for GOCOVRI® to include treatment for Parkinson’s disease patients receiving levodopa and experiencing OFF episodes

EMERYVILLE, Calif., June 04, 2020 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that its supplemental New Drug Application (sNDA) for GOCOVRI as a treatment for OFF episodes in Parkinson’s disease (PD) patients receiving levodopa-based therapy has been accepted for review by the U.S. Food and Drug Administration (FDA). The anticipated Prescription Drug User Fee Act (PDUFA) action date is February 1, 2021. GOCOVRI (amantadine) extended release capsules is approved to treat dyskinesia in PD patients treated with levodopa-based therapy, with or without other dopaminergic medications. In the sNDA, Adamas has proposed a revision to the indication statement to include...

Continue reading

Green Plains Partners Completes Debt Refinancing

OMAHA, Neb., June 04, 2020 (GLOBE NEWSWIRE) — Green Plains Partners LP (NASDAQ:GPP) and Green Plains Inc. (NASDAQ:GPRE) announced today the successful refinancing of the partnership’s debt facility which was arranged by Bank of America. The loan was approved by all of its existing lenders and became effective on June 4, 2020.“Green Plains Partners continues to maintain ample liquidity and strong cash flow supported by long-term minimum volume commitments,” said Todd Becker, president and chief executive officer of Green Plains Partners. “The closing of this transaction and repayment of debt over the next 18 months will be beneficial to all stakeholders, allowing us to allocate capital toward potential increases in future distributions.”The new loan will mature on December 31, 2021, and includes a $130.0 million term loan and a $5.0...

Continue reading

Grace Expands Portfolio for Water-Based Wood Coatings with Novel Matting Agents for Performance-Driven Finishes

COLUMBIA, Md., June 04, 2020 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE: GRA), a global leader in specialty silicas, today announced the introduction of two new premium matting agents especially designed for eco-friendly systems in water-based wood coatings: SYLOID® AQ 800 silica and SYLOID® AQ 880 silica. Specifically developed to ensure an extremely low-gloss finish, these new patent-pending specialty silicas put an end to the typical water spots and stains that have plagued wood coatings manufacturers.SYLOID® AQ 800 and SYLOID® AQ 880 silicas have been designed to offer superior matting properties with outstanding chemical resistance and clarity. Uniquely, the two silicas can be used alone or blended to achieve desired appearance and performance attributes. SYLOID® AQ silica series’ proof-of-concept and extensive in-market...

Continue reading

DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020

Montrouge, France, June 4, 2020DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020Virtual presentations will include data about children with and without multiple food allergies from the pivotal Phase III peanut allergy immunotherapy trial PEPITESBiologics License Application for investigational Viaskin Peanut under review with U.S. Food and Drug AdministrationDBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that seven abstracts, including four late breakers, highlighting new data from the Company’s pre-clinical and clinical food allergy programs were accepted at the European Academy of Allergy & Clinical Immunology (EAACI) Digital Congress, June 6-8, 2020. The virtual...

Continue reading

DBV Technologies va présenter des données sur l’immunothérapie par voie épicutanée et la qualité de vie dans le cas d’allergies alimentaires lors du congrès numérique EAACI 2020

Montrouge, France, le 4 juin (22 h 30 CEST) 2020DBV Technologies va présenter des données sur l’immunothérapie par voie épicutanée et la qualité de vie dans le cas d’allergies alimentaires lors du congrès numérique EAACI 2020Les présentations numériques intègreront des données chez l’enfant avec et sans allergies alimentaires multiples provenant de l’essai pivot de phase III PEPITES d’immunothérapie dans l’allergie à l’arachide.La demande de licence de produits biologiques pour le candidat-médicament Viaskin Peanut est en cours d’examen par la Food and Drug Administration aux Etats UnisDBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), une société biopharmaceutique de stade clinique, a annoncé aujourd’hui que sept résumés, dont quatre incluant des données récentes, mettant en évidence les nouvelles données des programmes...

Continue reading

Neuronetics to Present at the William Blair 40th Annual Growth Stock Conference

MALVERN, Pa., June 04, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the management team will participate in the William Blair 40th Annual Growth Stock Conference on Thursday, June 11, 2020. The Company is scheduled to present at the conference at 11:40 a.m. Eastern Time (10:40 a.m. Central Time) the same day via webcast.A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.neuronetics.com. A replay of the webcast will be archived on the website for approximately 90 days.About NeuroneticsNeuronetics, Inc. is a commercial-stage medical...

Continue reading

Hawthorn Bancshares Announces Results of 2020 Annual Meeting

JEFFERSON CITY, Mo., June 04, 2020 (GLOBE NEWSWIRE) — The Board of Directors of Hawthorn Bancshares, Inc. of Jefferson City, MO (NASDAQ: HWBK) announced that at the Company’s June 2, 2020 Annual Meeting of Shareholders, Philip D. Freeman, Kathleen L. Bruegenhemke and Jonathan D. Holtaway were re-elected as Class I directors to serve three-year terms expiring 2023.Mr. Freeman has served as director of Hawthorn Bancshares since 1993 and is currently the owner of Freeman Properties JCMO, LLC in Jefferson City, Missouri.  Ms. Bruegenhemke has served as director and as Chief Operating Officer of Hawthorn Bank since 2017.  Mr. Holtaway has served as director since 2019 and is President of Ategra Capital Management, LLC.Other members of the 7 member Board include Frank E. Burkhead, Kevin L. Riley, David T. Turner and Gus S. Wetzel, III. ...

Continue reading

Uniti Group Inc. to Participate in the Wells Fargo Securities 2020 Virtual 5G Forum

LITTLE ROCK, Ark., June 04, 2020 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Executive Vice President, Chief Financial Officer and Treasurer, Mark A. Wallace, and Ron Mudry, Chief Revenue Officer, are scheduled to participate in the Wells Fargo Securities 2020 Virtual 5G Forum on June 18, 2020. ABOUT UNITIUniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of wireless infrastructure solutions for the communications industry.  As of March 31, 2020, Uniti owns 6.3 million fiber strand miles, and other communications real estate throughout the United States. Additional information about Uniti can be found on its website at www.uniti.com.INVESTOR AND MEDIA CONTACTS:Mark...

Continue reading

La-Z-Boy Announces Moves to Strengthen and Re-Align Business

MONROE, Mich., June 04, 2020 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB), a global leader in residential furniture, today announced initiatives designed to strengthen the company and position it to thrive in the new external environment, marked by COVID-19.  Effective immediately, the company will reduce its global workforce by about 10%, or approximately 850 employees, across its manufacturing, retail and corporate locations, including the closure of its Newton, Mississippi upholstery manufacturing facility.  Production will be shifted to available capacity at the company’s Dayton, Tennessee, Neosho, Missouri, and Siloam Springs, Arkansas plants.  These changes are expected to leverage efficiencies across the business, improve competitiveness and position the company to drive long-term value for all stakeholders. The company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.